Aventiq Bio combines AI-driven intelligence with 20+ years of CRO/CDMO leadership to deliver repeatable outcomes.

Evaluates 150+ vetted CRO/CDMOs across 50+ parameters including regulatory history,
containment, data integrity, capacity, and culture.

Identifies failure points that typically appear only after tech transfer.

You know the risks before capital is committed.

Data-driven alignment of modality, scale, and regulatory pathway.

No long RFP cycles. No unqualified site visits.

Faster decisions, higher confidence, no wasted quarters.

Including ADC conjugation, viral vector production, HPAPI containment, and biologics scale-up.


First-time PPQ success and globally defensible data.

Quarterly audits, live risk monitoring, and crisis response.

AI-supported trend analysis flags deviations months before failure.

Predictability after the contract is signed-not just before.
Press Enter to search